Skip to main content

Day: October 26, 2021

Cerberus Sentinel Launches Secured Managed Services Providing Senior Support to Mitigate Cyber Risks

New offering includes C-Suite leadership, improves response times, increases employee productivity SCOTTSDALE, Ariz., Oct. 26, 2021 (GLOBE NEWSWIRE) — Cerberus Cyber Sentinel Corporation (OTC: CISO) (“Cerberus Sentinel”), a cybersecurity consulting and managed security services firm, today introduced its Cerberus Sentinel Secured Managed Services to help organizations step up their cybersecurity protections with security-focused, end-to-end network and device management solutions provided by a team of senior staff. Cerberus Sentinel’s full-scale secured managed services are an integral part of MCCP+, their holistic approach to cybersecurity, compliance and culture. This ensures that all strategic solutions are tailored specifically for each client. Cerberus Sentinel has long recognized that a company must incorporate a culture...

Continue reading

Akoya Biosciences Appoints Pascal Bamford, PhD, as SVP, R&D and Laboratory Operations

Accomplished leader in laboratory innovations and diagnosticsPascal Bamford, PhDPascal Bamford, PhD, SVP, R&D and Laboratory Operations, Akoya BiosciencesMARLBOROUGH, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Pascal Bamford, PhD, as Senior Vice President, Research and Development and Laboratory Operations. Dr. Bamford will be instrumental in accelerating the innovation of ground-breaking spatial biology solutions and the scaling of Akoya’s Advanced Biopharma Services (ABS) offering. Dr. Bamford joins Akoya with deep scientific and operational experience, leading teams in developing and implementing successful and innovative products and shepherding them through international regulatory agencies...

Continue reading

Avid Bioservices to Join S&P SmallCap 600 Index

TUSTIN, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will be added to the S&P SmallCap 600 Index, effective prior to the open of trading on Friday, October 29, 2021. “We are pleased to be added to the S&P SmallCap 600 Index as it is a further demonstration of the momentum that Avid continues to generate as we successfully execute against our comprehensive growth strategy. This recognition is also an important testament to the hard work and key contributions that every member of the Avid team has made to the company’s ongoing success,”...

Continue reading

NaturalShrimp Contracts Aquatic Veterinarian Christine Huynh to Lead Natural Aquatic Systems Subsidiary

DALLAS, TX, Oct. 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has developed and patented the first shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), today announced the appointment of Christine Huynh to lead the Company’s subsidiary Natural Aquatic Systems (NAS).  Christine Huynh is an aquatic veterinarian who works with commercial farms to improve health management systems and biological productivity. She has had 10+ years of experience working with intensive aquaculture production and consults internationally. She is the Director at Nautilus Collaboration, a consultancy firm specializing in aquaculture services. Christine holds a Bachelor of Veterinary Science from the University of Sydney.  In this role, Christine...

Continue reading

Salarius Pharmaceuticals to Report Third Quarter 2021 Financial Results and Highlight Recent Company Progress

Conference Call and Live Audio Webcast Scheduled for Thursday, November 4, 2021, 5:00 p.m. ET HOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other hematologic and solid tumors, today announced that the Company will host a conference call and live audio webcast on Thursday, November 4, 2021, at 5:00 p.m. ET, to discuss its corporate and financial results for the three and nine months ended September 30, 2021. Conference Call Information: Interested participants and investors may access the conference call by dialing either:(833) 423-0481 (U.S.) (918) 922-2375 (International) Conference ID: 1514667An audio webcast will be accessible via the Investors Events...

Continue reading

Galecto to Present at Upcoming Investor Conferences

BOSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that Galecto’s management team will be presenting virtually at the Credit Suisse Healthcare Conference and in-person at the Jefferies London Healthcare Conference. Galecto’s management team will be available for 1×1 meetings at both of these conferences. Details for the presentations are below:Credit Suisse Healthcare ConferenceDate: November 10, 2021Time: 8:00am ET   Jefferies London Healthcare ConferenceDate: November 16, 2021Time: 8:30am ETA live audio webcast will be available on the “News & Events” section of Galecto’s Investor website at https://ir.galecto.com/news-and-events/events....

Continue reading

Hamilton Reserve Bank and authID.ai Announce Deployment of Biometric Identity Authentication Services to Global Banking Clientele

Global bank brings high-level identity assurance to new digital banking services with the Temenos Infinity banking platform; combats identity fraud and eliminates need for passwords Denver, CO and Jessups Estate, Nevis, Saint Kitts & Nevis, Oct. 26, 2021 (GLOBE NEWSWIRE) —  authID.ai, [Nasdaq: AUID] (formerly Ipsidy), a leading provider of secure, mobile, biometric authentication, announced today that Hamilton Reserve Bank (HRB), a fully regulated global bank with worldwide offices (SWIFT: NIBTKNNE), has deployed authID.ai’s easy-to-integrate Identity as a Service (IDaaS) platform. HRB has deployed Verified™, authID.ai’s biometric multi-factor cloud-based authentication product that offers the ease of a “selfie” to confirm identity, thereby eliminating the use of vulnerable one-time passwords and knowledge-based questions...

Continue reading

First Merchants Corporation Announces Third Quarter 2021 Earnings Per Share

MUNCIE, Ind., Oct. 26, 2021 (GLOBE NEWSWIRE) — First Merchants Corporation (NASDAQ – FRME) has reported third quarter 2021 net income of $52.8 million compared to $36.2 million during the same period in 2020, an increase of 45.7 percent. Earnings per share for the period totaled $.98 per share compared to the third quarter of 2020 result of $.67 per share. Year-to-date net income totaled $157.8 million compared to $103.5 million during the nine months ended September 30, 2020, an increase of 52.5 percent. Year-to-date earnings per share totaled $2.92 compared to $1.91 during the same period in 2020. Total assets equaled $15.1 billion as of September 30, 2021 and loans totaled $9.0 billion. The Corporation experienced organic loan growth of $503.9 million, or 6.0 percent during the last twelve months, offset by the forgiveness...

Continue reading

Sysco to Release First Quarter Fiscal Year 2022 Financial Results on November 9

HOUSTON, Oct. 26, 2021 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its first quarter fiscal year 2022 financial results at 10 a.m. (Eastern) on Tuesday, November 9, 2021. All interested parties are invited to listen online at investors.sysco.com. Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation in the investor relations section of its website. A replay of the webcast will be available online shortly after the live webcast is completed. For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations section of its website, found at investors.sysco.com, as the primary channel for publishing key information to its investors, some of which may contain material and previously...

Continue reading

Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended September 30, 2021 and Declaration of Distributions of Common Stock for the Months Ending January 31, February 28, and March 31, 2022

GREENWICH, Conn., Oct. 26, 2021 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQL) (NasdaqGS: OXSQZ) (Nasdaq: OXSQG) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended September 30, 2021.As of September 30, 2021, net asset value (“NAV”) per share was $5.03, compared with the NAV per share of $4.91 at the prior quarter end.For the quarter ended September 30, 2021, we recorded GAAP net investment income of approximately $4.0 million, or $0.08 per share. We recorded net unrealized appreciation of approximately $5.6 million and net realized gains on investments of approximately $1.7 million for the quarter ended September 30, 2021, compared to net unrealized appreciation of approximately $2.5 million and net realized gains on investments...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.